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Bruton’s tyrosine kinase (BTK) is a member of the Tec
family of kinases, which is a subgroup of the nonrecep-
tor cytoplasmic protein tyrosine kinases. BTK has been
shown to be important in the proliferation, differentia-
tion, and signal transduction of B cells. Mutations in
BTK result in B cell immune deficiency disorders, such
as X-linked agammaglobulinemia in humans and
X-linked immunodeficiency in mice. Although BTK
plays multiple roles in the life of a B cell, its functional
role in neuronal cells has not been elucidated. In the
present study, we demonstrate that BTK activates tran-
scription factor, cAMP response element (CRE)-binding
protein (CREB), and subsequent CRE-mediated gene
transcription during basic fibroblast growth factor
(bFGF)-induced neuronal differentiation in immortal-
ized hippocampal progenitor cells (H19-7). The kinase
activity of BTK is also induced by bFGF, and BTK di-
rectly phosphorylates CREB at Ser-133 residue, indicat-
ing that BTK has a dual protein kinase activity. In ad-
dition, blockading BTK activation significantly inhibits
CREB phosphorylation as well as the neurite outgrowth
induced by bFGF in H19-7 cells. These results suggest
that the activation of BTK and the subsequent phospho-
rylation of CREB at Ser-133 are important in the neuro-
nal differentiation of hippocampal progenitor cells.
Growth factors act by binding to cell surface receptors to elicit
the regulation of cell growth and differentiation (1). This, in turn,
triggers a variety of intracellular signaling pathways that ulti-
mately control cell physiology. The activation of signaling cas-
cades changes gene expression patterns through the functional
modulation of various transcription factors. These processes al-
low cells to coordinate long term physiological adaptation.
cAMP response element-binding protein (CREB)1 is a central
transcription factor that mediates cAMP- and calcium-depend-
ent gene expression through the cAMP response element (2).
Moreover, CREB activity is regulated by multiple kinases after
various kinds of stimulation. Many Ser/Thr kinases can phos-
phorylate CREB, including protein kinase C (3), Ca2/calmod-
ulin-dependent protein kinases (4, 5), Ras-dependent p105 ki-
nase (6), p90rsk (7), and Rsk2 (8). CREB is believed to be
necessary for long term potentiation in invertebrates and ver-
tebrates (9). Furthermore, the activation of CREB plays an
important role in neuronal differentiation (10, 11). Specific
roles for CREB in neuronal development have been found by
manipulating CREB function in vivo and in vitro (12).
Bruton’s tyrosine kinase (BTK) family kinases are members
of a group of nonreceptor tyrosine kinases, which include BTK,
Tec, and Bmx. These kinases have a canonical pleckstrin ho-
mology (PH) domain at the amino terminus, followed by cys-
teine-rich and proline-rich regions, which together have been
termed the Tec homology domain (13). The proline-rich portion
of the Tec homology domain mediates interactions with the Src
homology-3 (SH3) domains in vitro and may stabilize regula-
tory interactions with Src-type kinases in vivo (14, 15). The
expression of BTK is restricted to a subset of B cells and
myeloid cell (16) and is involved in signaling of B cell antigen
receptor, mast cell FcR, interleukin-5 receptor, and interleu-
kin-6 receptor. Mutations in BTK are associated with X-linked
agammaglobulinemia in humans and X-linked immunodefi-
ciency and an impaired B cell proliferation in mice. A large
number of proteins interact with BTK and are phosphorylated
in a BTK-dependent manner. These include BAP-135, pp70,
WASP, c-Cbl, Sam-68, vav, and EWS (16). Although these
proteins are putative BTK regulators or effectors by virtue of
their binding activity and/or BTK-dependent phosphorylation,
there is no direct biological evidence that demonstrates their
role in BTK signaling.
Although BTK is expressed ubiquitously in nearly all cells of
the hematopoietic lineages, only B cells have been shown to be
vulnerable with respect to functional integrity. In addition, the
molecular mechanisms underlying BTK activation in other
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cells, including neuronal cells, are not well understood. Inter-
estingly, one of the genes in the breakpoint region of 7q11.23 in
Williams-Beuren syndrome, a neurodevelopmental disorder
with multisystemic manifestations, which is caused by a het-
erozygous deletion in 7q11.23, encodes BAP-135, a phosphoryl-
ation target of BTK (17). This finding suggests that the signal
transduction mediated via BTK activation appears to be im-
portant for normal neural development. Recently it was shown
that a small pool of BTK could translocate to the nucleus,
although it continues to be present predominantly in the cyto-
plasm (18). BTK can also translocate to the plasma membrane
upon growth factor stimulation (19). To identify the upstream
signal transduction pathways in which CREB functions, we
sought to identify proteins that interact specifically with and
directly phosphorylate CREB in vivo. In the present study, we
demonstrate that CREB is a substrate for BTK phosphoryla-
tion. Interestingly, active BTK directly phosphorylates CREB
on Ser-133, suggesting that BTK could be a member of dual
specificity protein kinases that are capable of phosphorylating
both serine/threonine and tyrosine residues. Mutations of BTK
which impair its activation or the suppression of endogenous
BTK by siRNA duplexes lead to the abolishment of BTK-de-
pendent phosphorylation of CREB and to a significant inhibi-
tion of neurite outgrowth induced by neurogenic growth factor.
These findings suggest that CREB lies downstream of BTK in
a signaling pathway started by neurogenic bFGF, and CREB
activation via BTK is important for neuronal differentiation in
central nervous system hippocampal progenitor cells.
EXPERIMENTAL PROCEDURES
Materials—Peroxidase-conjugated anti-rabbit and anti-mouse IgGs
were purchased from Zymed Laboratories, Inc. (San Francisco). Dul-
becco’s modified Eagle’s medium, fetal bovine serum (FBS), and Lipo-
fectAMINE PLUS reagent from were from Invitrogen. Protein A-Sepha-
rose was from Amersham Biosciences. Anti-CREB and anti-phospho-
CREB antibodies were from PerkinElmer Life Sciences and Upstate
Biotechnology (Lake Placid, NY), respectively. Anti-rabbit polyclonal
anti-BTK antibodies were from Santa Cruz Biotechnology (Santa Cruz,
CA). ECL reagents and [-32P]ATP were from PerkinElmer Life Sci-
ences. Selective Src kinase inhibitor PP1 was from A. G. Scientific, Inc.
(San Diego). The synthetic yeast dropout medium (SD/-T, SD/-L, SD/-
HLT) and yeast extract peptone dextrose containing adenine were from
Bio 101, Inc. (Vista, CA). 3-Amino-1,2,4-triazole and 5-bromo-4-chloro-
3-indolyl-D-galactoside were from Sigma and Promega, respectively.
The human fetal brain cDNA library was from Clontech. Human bFGF
was from Sigma, and the luciferase assay kit was purchased from
Promega. pVP16-CREB and pVP16-CREB S133A were gifts from K.
Saeki (Research Institute in International Medical Center, Tokyo, Ja-
pan). The hemagglutinin-tagged wild type or kinase-inactive BTK mu-
tants (K430E, in which the Lys-430 in the kinase domain of BTK was
mutated to Glu) were gifts from A. L. Roy (Tufts University School of
Medicine, Boston). The double tyrosine-mutated BTK construct
(pEGFP-BTK-2MT-Y223A/Y551F, in which Tyr-223 in the SH3 domain
of BTK and Tyr-551 in the kinase domain were replaced by Ala and Phe,
respectively) was generously provided by A. J. Mohamed (Karolinska
Institute, Huddinge, Sweden). A eukaryotic expression vector encoding
constitutive active BTK, pSR-MSVTK-caBTK, in which Glu-41 residue
in the PH domain was replaced by Lys, was kindly provided by O. N.
Witte (University of California, Los Angeles). A prokaryotic expression
plasmid encoding bacterially recombinant GST-caBTK was constructed
by inserting the NotI fragment of the caBTK sequence digested from
pSR-MSVTK-caBTK into pGEX4T1 vector (Amersham Biosciences).
The plasmids encoding v-Src (pMvSrc) and mutant Src (pcSrc295Arg)
were gifts from D. Foster (Hunter College of the City University of
New York).
Yeast Two-hybrid Assay—The bait vector for yeast two-hybrid assay
was constructed by subcloning the mutant CREB cDNA, in which
RRPSY (from amino acids 130–134) was replaced by RRSLY, into
pHybTrp/Zeo. Human fetal cDNA library subcloned into prey vector
(pACT2) was purchased from Clontech. All yeast two-hybrid screening
protocols were performed as described previously (20). Sequencing of
the inserts in positive library plasmids was performed using an auto-
matic DNA sequencer (ALF express, Amersham Biosciences).
Cell Culture—Immortalized hippocampal neuronal cells (H19-7)
were grown on poly-L-lysine-coated cell culture dishes in Dulbecco’s
modified Eagle’s medium containing 10% FBS and 100 units/ml peni-
cillin-streptomycin (21). The cells were maintained at 33 °C under 5%
CO2 and stimulated with 10 ng/ml neurogenic growth factor, bFGF, to
induce neuronal differentiation, after being treated with serum-free N2
medium for 2 days, as described previously (22). To prepare the cell
lysates, cells were rinsed twice with ice-cold phosphate-buffered saline
and then solubilized in lysis buffer (20 mM Tris, pH 7.9, containing 1.0%
Triton X-100, 1 mM Na3VO4, 137 mM NaCl, 1 g/ml leupeptin, 1 g/ml
aprotinin, 1 mM sodium orthovanadate, 1 mM EGTA, 10 mM NaF, 1 mM
tetrasodium pyrophosphate, 5 mM Na2EDTA, 10% glycerol, 1 mM
-glycerophosphate, 0.1 g/ml p-nitrophenyl phosphate, and 0.2 mM
phenylmethylsulfonyl fluoride). The cells were removed by scraping,
and the supernatants were collected after centrifugation for 15 min at
14,000  g at 4 °C. Primary cortical neurons were obtained from rat
fetal brain on embryonic day 15 and triturated. Dissociated cells were
plated in 24-well culture plates coated with 100 mg/ml poly-D-lysine and
4 mg/ml laminin and maintained in Eagle’s minimal essential medium
(Eagle’s salts, glutamine-free) supplemented with 21 mM glucose, 5%
FBS (Biofluid), 5% horse serum, and 2 mM glutamine, at 37 °C under a
humidified atmosphere of 95% air plus 5% CO2. Plating density was
adjusted to 105 cells/culture well. After 2 days, the culture medium was
replaced with growth medium identical to plating medium, but lacking
fetal serum, and then fed twice a week. The U937 cell line was cultured
in RPMI 1640 supplemented with 10% FBS and kept in a humidified
incubator at 37 °C in 5% CO2 plus 95% air. SH-SY5Y cell line was
grown on Dulbecco’s modified Eagle’s medium containing 10% FBS and
100 units/ml penicillin-streptomycin. The cells were maintained in a
humidified incubator at 37 °C under 5% CO2 condition.
Immunohistochemistry—Adult mice were perfused with 4% parafor-
maldehyde in 0.1 M phosphate buffer, pH 7.4. Brains were removed and
postfixed in the same buffer for 24 h at 4 °C. Thereafter, they were
cryoprotected in 30% sucrose, frozen on dry ice, and sectioned on a
cryostat. Serial coronal or sagittal sections (40 m thick) were collected
in a cryoprotectant solution (30% glycerol, 30% ethylene glycol, 40% 0.1
M phosphate buffer, pH 7.4). Immunohistochemistry was performed by
using polyclonal anti-BTK antibodies and developed using avidin-biotin
technique (Elite ABC kit, Vector Laboratories).
DNA Transfection and Luciferase Reporter Assay—H19-7 cells were
plated at a density of 2  106 cells/well in 100-mm dishes, were trans-
fected when 7090% confluent with suitable plasmid constructs using
LipofectAMINE PLUS reagent according to the manufacturer’s instruc-
tions. The luciferase reporter construct, pCRE-TK-Luc, was transiently
cotransfected with the kinase-inactive mutant BTK kinases (Y223A/
Y551F, R28C, or K430E), and luciferase activity was measured using a
luciferase assay kit (Promega) and a luminometer (EG & G Berhold,
Germany). The CRE-lacking TK promoter construct (pTK-Luc) was
used as a negative control throughout.
Microinjection of H19-7 Cells—Around 4.5  104 cells were seeded to
poly-L-lysine-coated coverslips placed on 6-well plate and grown at
33 °C. After the cells grew to the desired densities, anti-rabbit poly-
clonal anti-BTK antibody or anti-mouse control IgG (0.5 mg/ml) was
microinjected with the injection buffer (50 mM HEPES, pH 7.4, 40 mM
NaCl) containing 0.5% dextran rhodamine into the cell nuclei. Micro-
injection was done with an Eppendorf Micromanipulator 5171, Micro-
injector FemtoJet, and Olympus DP50 microscope. The cells were re-
covered in 10% FBS at 33 °C overnight before being shifted to 39 °C in
N2 medium and were treated with 10 ng/ml bFGF. The cells containing
dextran rhodamine were examined by immunofluorescence microscopy.
Immunoprecipitation—1 g of polyclonal anti-BTK antibody was
incubated with 600 g of cell extract prepared in lysis buffer overnight
at 4 °C. 40 l of a 1:1 suspension of protein A-Sepharose beads was
added and incubated for 2 h at 4 °C with gentle rotation. The beads
were pelleted and washed extensively with cell lysis buffer. Bound
proteins were dissociated by boiling in SDS-PAGE sample buffer, and
whole protein samples were separated on SDS-polyacrylamide gel.
Western Blot Analysis—Whole-cell lysates were separated by electro-
phoresis through a 10% SDS-polyacrylamide gel and transferred to a
nitrocellulose membrane (Millipore, Japan). The membrane was
blocked in TBST buffer containing 20 mM Tris, pH 7.6, 137 mM NaCl,
0.05% Tween 20, and 3% nonfat dry milk for 3 h, and then incubated
overnight at 4 °C in 3% nonfat dry milk containing anti-phospho-CREB,
anti-CREB, or anti-BTK antibodies (Santa Cruz Biotechnology). The
membrane was washed several times in TBST and then incubated with
secondary IgG-coupled horseradish peroxidase antibody (Zymed Labo-
ratories Inc.). After 60 min, blots were washed several times with TBST
and visualized by enhanced chemiluminescence.
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Analysis of bFGF-induced Neuronal Differentiation in H19-7 Cells—
H19-7 cells were grown on poly-L-lycine-coated 6-well dishes to reach
7090% confluence. The cells were transfected with 1 g of mammalian
constructs encoding wild type or dominant negative BTK mutants, such
as kinase-inactive K430E or Y223A/Y551F mutant of BTK using Lipo-
fectAMINE reagent. The next day the cells were switched to N2 me-
dium and cultured at 39 °C for 2 days. They were then treated with 10
ng/ml bFGF for 48 h, and any morphological changes were noted.
Differentiated cells were defined as cells with a round and refractory
cell body and at least one neurite of length exceeding the diameter of the
cell body.
In Vitro BTK Kinase Assay—H19-7 cells grown in serum-free N2
medium for 2 days at 39 °C were treated with bFGF. The cells were
harvested and lysed in lysis buffer, and 600 g of the proteins so
obtained were incubated with polyclonal BTK antibody overnight at
4 °C. The immunocomplexes were then added to 40 l of a 1:1 suspen-
sion of protein A-Sepharose. After washing the samples three times in
lysis buffer, kinase reactions were carried out at 30 °C for 60 min in 20
l of kinase buffer containing 20 mM HEPES, pH 7.2, 5 mM MnCl2, 200
M sodium orthovanadate, 5 g of acid-treated enolase, 10 M ATP, 5
Ci of [-32P]ATP, and 5 g of wild type GST-CREB or mutant GST-
CREB S133A as a substrate. The reactions were stopped by adding
SDS-sample buffer and analyzed by SDS-PAGE and autoradiography.
Assay of Bacterially Recombinant Fusion GST-BTK Protein with
Constitutive Active Kinase Activity—The Sepharose-4B beads prebound
to bacterially expressed GST-BTK with a constitutive active kinase
activity were prepared by using Bulk GST purification module (Amer-
sham Biosciences). 30 l of beads were suspended in 200 l of binding
buffer (25 mM Tris-HCl, pH 7.5, 1 mM dithiothreitol, 30 mM MgCl2, 40
mM NaCl, 0.5% Nonidet P-40) and mixed with 300 g of either wild type
GST-CREB or mutant GST-CREB S133A proteins for 2 h at 4 °C. After
the bead pellet was washed twice with kinase buffer containing 20 mM
HEPES, pH 7.2, 5 mM MnCl2, 200 M sodium orthovanadate, and 10 M
ATP, the pellet was resuspended in 20 l of kinase buffer, and kinase
reactions were carried out by adding 5 Ci of [-32P]ATP at 30 °C for 60
min. The reactions were terminated by adding of SDS-sample buffer,
and the phosphorylated proteins were analyzed by SDS-PAGE followed
by autoradiography.
Proteomic Analysis of BTK Immunocomplexes—The total cell lysates
were immunoprecipitated with a polyclonal anti-BTK IgG. After the
beads were washed three times with lysis buffer, bound proteins were
dissociated by boiling of the beads in SDS-PAGE sample buffer, and the
eluted whole proteins were separated on 8% SDS-polyacrylamide gel.
Next the gel was stained with Coomassie Blue R-250 dye followed by
destaining overnight, and the individual protein band was digested.
Each gel piece was then immersed in 100 l of acetonitrile, dried under
vacuum centrifugation for 10 min, rehydrated in trypsin buffer contain-
ing 1 g/l trypsin plus 50 mM ammonium bicarbonate, immersed in
100 l of 50 mM ammonium bicarbonate, pH 8.0, incubated for 18 h at
37 °C, and analyzed by MALDI-TOF MS.
In Vitro In-gel Kinase Assay—An 8.0% SDS-polyacrylamide gel was
prepared in the presence of 50 g/ml bacterial recombinant wild type
GST-CREB or mutant GST-CREB-S113A proteins as a phosphorylation
substrate. The total cell extracts were prepared after the stimulation of
H19-7 cells with bFGF and applied to the gel. All gel renaturation and
phosphorylation protocols were performed as described previously (22).
Construction of siRNA Duplexes and Transfection—The siRNA du-
plexes for BTK were designed as described elsewhere (50). The
cDNA-targeted region and the sequence of the siRNA duplexes for BTK
are as follows: targeted region (cDNA), 895-GGGAAAGAAGGAGGTT-
TCA-913; sense siRNA, 5-GGGAAAGAAGGAGGUUU CAUU-3; anti-
sense siRNA, 3-UUCCCUUUCUUCCUCCAAAGU-5. The siRNA du-
plexes of BTK were transfected by using LipofectAMINE PLUS reagent
according to the manufacturer’s instructions.
RESULTS
Identification of Novel CREB Kinase(s) Activated during
Neuronal Differentiation in Immortalized Hippocampal Pro-
genitor Cells—The conditionally immortalized hippocampal
cell line (H19-7) was generated by transducing temperature-
sensitive SV40 large T antigen into rat embryonic day 17
hippocampal cells (21). Central nervous system progenitor
H19-7 cells have the ability to differentiate terminally into
neuronal cells, at a nonpermissive temperature (39 °C), in the
presence of several agents, such as bFGF. Differentiating
H19-7 cells express several neuronal markers, including neu-
rite outgrowth and neurofilament proteins. In an earlier study
we showed that CREB phosphorylation and subsequent CRE-
mediated gene transcription play an important role during
bFGF-induced neuronal differentiation in H19-7 cells (23). In-
terestingly, CREB phosphorylation is not likely to be mediated
by any of the previously known signaling pathways such as the
MAPK, protein kinase A, protein kinase C, p70S6K, or Ca2/
calmodulin-dependent protein kinase pathways. These find-
ings suggest that the activation of a novel protein kinase-
signaling pathway is required to induce bFGF-responsiveness
(23). Furthermore, the activation of two previously unreported
CREB kinases of76 and 120 kDa by bFGF was observed by in
vitro in-gel kinase assay with recombinant GST-CREB fusion
proteins as substrates. CREB phosphorylation on Ser-133 is
considered to be a critical step in CREB transcriptional activa-
tion. Moreover, the modification of either the catalytic or the
regulatory domain of the transcription factor is frequently used
to enhance and to stabilize complex formation with its kinase
in the yeast two-hybrid assay (24–26). The same assay was
performed to identify the upstream signal transduction path-
ways leading to CREB phosphorylation and to isolate the novel
CREB kinase(s), using CREB as bait, in which the critically
regulatory Pro-132 and Ser-133 residues were changed to Ser-
132 and Leu-133. As a result of screening of human fetal brain
cDNA library, many CREB-interacting proteins were identi-
fied, including histone deacetylase and Dyrk1A (20). In addi-
tion, it was found that BTK specifically interacts with CREB in
yeast cells (data not shown). Because the molecular size of BTK
(77 kDa) is comparable with that of one of the novel CREB
kinases (23) and BTK plays an integral role in the differentia-
tion and signal transduction directed by antigen-receptor in B
cells, its functional role during neuronal differentiation was
further examined.
Specific Binding between Active CREB and BTK during Neu-
ronal Differentiation in H19-7 Cells—First, we examined
whether BTK is expressed in various types of mammalian
primary and transformed neuronal cells. As shown in Fig. 1A,
immunohistochemical analysis has shown that significant lev-
els of BTK are expressed in a variety of mice central nervous
system regions, such as neocortex, cerebral cortex, cerebellum,
and hippocampus. Furthermore, considerable levels of BTK
protein are normally present in transformed neuronal cells.
These includes human neuroblastoma SH-SY5Y cell line, im-
mortalized rat embryonic hippocampal H19-7 cells, and rat
pheochromocytoma PC12 cell line, compared with that in sev-
eral immune B cells as a control (Fig. 1B). We also observed
that BTK is enriched in the cell extracts from rat whole brain
and cerebellum (Fig. 1B). These observations suggest that,
outside of hematopoietic cells, BTK could play a role during cell
differentiation and signal transduction in neuronal cells.
To confirm the previous finding that bFGF exerts its stimu-
latory effect on the activation of CREB (23), Western blot
analysis was performed using an antibody specific for the Ser-
133-phosphorylated form of CREB. During the differentiation
of H19-7 cells by bFGF, the Ser-133 residue in the CREB
protein was phosphorylated, but endogenous CREB levels were
not markedly changed (Fig. 1C). Then we examined whether
BTK specifically binds to CREB in hippocampal H19-7 cells.
The H19-7 cell extracts obtained after neurogenic bFGF stim-
ulation were immunoprecipitated using anti-BTK antibodies
and then blotted using anti-phospho-CREB antibodies. As
shown in Fig. 1C, the expression of BTK is not markedly
changed by bFGF. However, the addition of bFGF leads to a
marked increase in the specific binding between BTK and
phospho-CREB. Furthermore, when the cell lysates were im-
munoprecipitated with anti-phospho-CREB antibodies and an-
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alyzed by Western blot using anti-BTK IgG, it was found that
the addition of bFGF resulted in specific binding between BTK
and phospho-CREB (Fig. 1C). These results suggest that BTK
interacts with active CREB in a specific way, during bFGF-
induced neuronal differentiation in H19-7 cells.
BTK Is Activated Selectively by Neurogenic bFGF, but Not by
Mitogenic EGF, in H19-7 Cells—Because BTK is activated by
tyrosine phosphorylation in the activation loop of the catalytic
domain, we assessed whether BTK is activated by neurogenic
bFGF in H19-7 cells. The cells were stimulated with bFGF, and
cell lysates were then immunoprecipitated with anti-BTK an-
tibodies. The precipitated mixtures were separated by SDS-
PAGE and analyzed using anti-phosphotyrosine antibody. As
shown in Figs. 2 and 3A, tyrosine phosphorylation of endoge-
nous BTK was observed during neuronal differentiation in
H19-7 cells. The transient overexpression of dominant negative
BTK mutants was used to block the activation of BTK (18, 27).
The activity of BTK is partially regulated by transphosphory-
lation of its kinase domain (by Src family kinases) at residue
Tyr-551 and subsequent autophosphorylation at Tyr-223.
When the dominant negative BTK mutant BTK-Y551F/Y223A,
in which Tyr-223 in the SH3 domain and Tyr-551 in the kinase
domain were replaced by Ala and Phe, was overexpressed in a
transient manner, the tyrosine phosphorylation of BTK was
repressed extensively, compared with mock-transfected control
cells (Fig. 2). These results suggest that neurogenic factor
bFGF induces the activation of BTK in H19-7 cells.
Differences in CREB phosphorylation are known to be criti-
cal in the determination and regulation of EGF-mediated pro-
liferation and bFGF-induced differentiation in neuronal H19-7
cell (23). In contrast to the prolonged CREB phosphorylation by
neurogenic bFGF, mitogenic EGF treatment induces rapid but
transient CREB phosphorylation in H19-7 cells (23). This find-
ing suggests that stable CREB activation by bFGF is an im-
portant determinator of the fate of hippocampal progenitor
cells, in terms of their terminal differentiation to neuronal
cells. To verify that the activation of BTK occurs in a neuro-
genic growth factor-specific way, the effect of EGF stimulation
on endogenous BTK phosphorylation was examined at mito-
genic culture temperatures. As shown in Fig. 3B, EGF fails to
phosphorylate the tyrosine residue of BTK at 33 °C, when the
simian virus large T antigen is active. These results suggest
that the activation of BTK is induced selectively by a neuro-
genic factor, but not by a mitogenic factor, and BTK plays a role
during neuronal differentiation in H19-7 cells.
BTK Directly Phosphorylates CREB at Ser-133 in Response
to bFGF—Next, we examined whether active BTK could phos-
phorylate CREB in H19-7 cells. The cell lysates obtained after
bFGF treatment were immunoprecipitated using anti-BTK an-
tibodies. Immunocomplex kinase assays were performed using
bacterial recombinant GST-CREB as a substrate, and the phos-
phorylated substrate was visualized autoradiographically. As
FIG. 1. Bruton’s tyrosine kinase, but not its kinase-inactive
mutant, interacts with active CREB during neuronal differen-
tiation in H19-7 cells. A, localization of BTK in mouse brain. After
perfusion with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4,
adult mice brains were fixed in the same buffer for 24 h at 4 °C. The
brains were cryoprotected in 30% sucrose, frozen on dry ice, and sec-
tioned on a cryostat. After serial sections were collected, immunohisto-
chemical analysis was performed by using either preimmune serum (I)
or polyclonal anti-BTK antibodies (II–VI). Micrographs are arranged
with gross (I, II, IV) and enlarged structure (III, V, VI) of specified
central nervous system regions. I, II, and III, cerebral cortex; IV and V,
ventral neocortical area; VI, cerebellum. B, BTK expression in various
neuronal cells. Where indicated, the cell extracts were isolated from
either rodent brain, neuronal and hematopoietic cells, and the expres-
sion of endogenous BTK was examined by Western blot analysis. PC,
rat pheochromocytoma PC12 cells; SH, human dopaminergic neuro-
blastoma SH-SY5Y cells; CB, rat cerebellum; WB, rat whole brain;
Ram, human B lymphocyte Ramos cell; U9, human lymphocyte U937
cell line; KG, human leukemia KG1 cells; K5, human malignant mye-
loid K532 cells. C, specific binding between CREB and BTK in neuronal
H19-7 cells. After H19-7 cells were stimulated with 10 ng/ml bFGF for
30 min, the phosphorylated and endogenous CREB proteins were iden-
tified by Western blot analysis (left panel). Where indicated, H19-7 cells
were either untreated (No T) or stimulated with 10 ng/ml bFGF for 30
min. Total cell lysates were immunoprecipitated (IP) with polyclonal
anti-BTK or anti-pCREB antibodies and blotted with an anti-phospho-
CREB or anti-BTK IgG, as indicated. The quantity of immunoprecipi-
tated BTK was determined by Western blot analysis using anti-poly-
clonal anti-BTK antibodies, respectively (right panel).
FIG. 2. FGF-induced tyrosine phosphorylation of BTK in H19-7
cells. Where indicated, the cells were either mock-transfected (No T or
C) or transiently transfected with 5 g of plasmids encoding kinase-
inactive BTK (Y551F/Y223A). The cells were untreated or stimulated
with 10 ng/ml bFGF for 30 min under differentiating condition. Total
cell lysates were immunoprecipitated (IP) using BTK antibodies and
detected with an anti-phospho-Tyr or anti-BTK IgG. The levels of ex-
ogenous added fusion GFP-BTK-Y551F/Y223A proteins were examined
by polyclonal anti-GFP IgG. No T, no treatment; C, control; 2MT,
Y551F/Y223A.
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shown in Fig. 4A, the phosphorylation of CREB significantly
increased in the presence of bFGF. As a control for equal
protein loading, we measured the amount of endogenous BTK
enzymes in the immunoprecipitates by using anti-BTK IgG.
Interestingly, when the phosphorylation-resistant GST-CREB
mutant, in which the Ser-133 residue of CREB had been re-
placed by alanine, was used as a substrate, no significant
CREB phosphorylation was observed compared with wild type
CREB (Fig. 4B). To test the possibility that, rather than BTK,
other contaminated Ser/Thr kinase(s) in the BTK-immunocom-
plexes phosphorylate CREB on Ser-133 residue in response to
bFGF, the immunoprecipitated protein complexes prepared
with anti-BTK antibodies were analyzed by SDS-PAGE fol-
lowed MALDI-TOF MS. Although seven major proteins (aside
from CREB) were detected in the BTK-protein complexes, in-
cluding myosin, glucose-regulated protein precursor-78 immu-
noglobulin heavy chain binding protein, vimentin, platelet-
derived growth factor receptor-, actin-, minor striated-
muscle tropomyosin-, tropomyosin-, and myosin regulatory
light chain 2-A, we could not observe the presence of potential
Ser/Thr kinase(s) in the BTK-immunocomplexes.
To verify the serine-specific kinase activity of BTK, an in
vitro in-gel kinase assay was performed using polyacrylamide
gel prepared in the presence of bacterially recombinant fusion
GST-CREB or mutant GST-CREB S133A proteins. Equal pro-
tein-containing anti-BTK-IgG immunoprecipitates from H19-7
cells that had been stimulated with 10 ng/ml bFGF for 30 min
were resolved by SDS-PAGE, renatured, and assayed for CREB
phosphorylation in the gel. The results show that a 77-kDa
band corresponding to the molecular size of BTK phosphorylate
CREB in the gel (Fig. 4C). No significant kinase activity was
detected when the mutant GST-CREB S133A was used as a
substrate (Fig. 4C).
To ensure that the serine-specific kinase activity of BTK
which we identified is not an artifact of the renaturation proc-
ess, we have verified that active BTK is capable of phosphoryl-
ating CREB at Ser-133 in vitro. To do this, a prokaryotic GST
fusion expression plasmid encoding caBTK mutant was con-
structed by replacing Glu-41 residue in the PH domain of BTK
with Lys (28). Then, in vitro kinase activity of the recombinant
caBTK proteins was examined using either bacterially recom-
binant wild type GST-CREB or GST-CREB S133A mutant as a
substrate. As shown in Fig. 4D, the constitutive active GST-
BTK (GST-caBTK) significantly phosphorylated GST-CREB in
vitro, whereas mutant GST-CREB S133A proteins were not
phosphorylated by GST-caBTK. Taken together, our data sug-
gested that active BTK directly phosphorylates CREB on Ser-
133, and thus BTK has a dual specific protein kinase activity.
Furthermore, the transient overexpression of the kinase-
deficient BTK mutants, including BTK-K430E, in which the
Lys-430 in the kinase domain was mutated to Glu, or BTK-
Y223A/Y551F, significantly diminished bFGF-stimulated
CREB phosphorylation, versus the control cells or the cells
transfected with an expression vector encoding wild type BTK
(Fig. 5A). When H19-7 cells were transfected with the plasmid
encoding GFP fused with kinase-deficient BTK double mutant
(Y223A/Y551F), in vitro kinase assay using GST-CREB as a
substrate showed that the elevated levels of phospho-CREB
induced by the addition of bFGF are significantly decreased by
the overexpression of kinase-inactive BTK mutant (Fig. 5B).
Overall these results suggest that BTK directly phosphorylates
CREB during the differentiation of H19-7 cells, and its effect is
specifically related to the CREB Ser-133 residue.
Effect of BTK Activation on CRE-dependent Gene Transcrip-
tion during Neuronal Differentiation—To assess whether BTK
exerts a stimulatory effect on CRE-mediated gene transcription
as well as on CREB activation, we assayed the gene expression
of CRE-containing thymidine kinase (TK) promoter-reporter
construct. Treatment of mock-transfected control H19-7 cells
with bFGF for 4 h resulted in increased CRE-mediated gene
transcription (Fig. 6). To test the role of BTK activation in
CRE-mediated gene transcription, H19-7 cells were transfected
transiently with pCRE-TK-Luc reporter plasmid plus plasmid
encoding a dominant negative BTK mutant, namely, K430E or
Y223A/Y551F. The expression of any of these kinase-inactive
BTK proteins significantly suppressed the activation of lucif-
erase activity by bFGF, compared with mock-transfected con-
trol cells (Fig. 6). These results indicate that the stimulation of
H19-7 cells with bFGF causes the activation of CRE-mediated
gene transcription, possibly through the activation of BTK and
subsequent CREB phosphorylation in embryonic hippocampal
H19-7 cells.
Effect of BTK Activation on bFGF-induced Neuronal Differ-
entiation in H19-7 Cells—The functional role of BTK activation
during FGF-induced differentiation in H19-7 cells was exam-
ined further. Treatment of H19-7 cells with bFGF induced
differentiation at 39 °C, at which large T antigen is inactivated.
Differentiated cells are known to be resistant to mitogenic
stimulation by serum and to express neuronal markers, such as
neurofilament and brain type II sodium channels (21). In the
present study, parental or mutant BTK expression vectors
were transfected, and subsequently the formation of neurite
outgrowth was analyzed in H19-7 cells (Fig. 7A). As shown in
Fig. 7A, the addition of bFGF plus parental vector led to cells
with a round and refractory cell body and with at least one
neurite longer than the diameter of the cell body. As shown in
Fig. 7B, mock-transfected control cells generated high levels of
differentiated cells (71%) in two separate transfection exper-
iments. However, the cells in the mutant BTK-transfected pop-
ulation had remarkably reduced levels of differentiated cells
(36%) (Fig. 7, A and B). Taken together, these results suggest
that relatively stable BTK activation by bFGF is likely to play
FIG. 3. BTK is activated by neurogenic bFGF, but not by mito-
genic EGF, in H19-7 cells. Where specified, H19-7 cells were stimu-
lated with either 50 ng/ml EGF under proliferation conditions or 10
ng/ml bFGF under differentiation conditions for the indicated times.
Endogenous BTK was immunoprecipitated from cell lysates, and the
BTK-bound protein mixtures were blotted with monoclonal anti-phos-
photyrosine (pTyr) antibodies. As a control, the quantity of BTK immu-
noprecipitated was determined by Western blot analysis using anti-
BTK antibodies (lower panel). A, bFGF at 39 °C; B, EGF at 33 °C; IP,
immunoprecipitation; No T, no treatment.
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an important role in the differentiation of hippocampal progen-
itor H19-7 cells.
To confirm the hypothesis that the activation of BTK is
required for neuronal differentiation in a single cell level,
measurement was done on single cells where the individual
cells expressed the protein of interest. The H19-7 cells were
transiently transfected with a vector to express green fluores-
cent protein (GFP) fused with kinase-inactive BTK mutant,
pEGFP-BTK-2MT, and subsequently the effect on bFGF-medi-
ated differentiation was examined. Analysis of the GFP-fluo-
rescent cells showed that the inhibition of BTK makes a re-
markable inhibition of cellular differentiation. (Fig. 8, A and
C). Meanwhile, the control cells transfected with an empty
expression vector encoding GFP alone showed a characteristic
neurite outgrowth, suggesting that the blockade of neuronal
differentiation is caused by the expression of dominant nega-
tive BTK mutant but not by GFP. Similar results were ob-
tained when H19-7 cells were microinjected with anti-BTK
antibodies and differentiated by bFGF (Fig. 8, B and C).
Effect of BTK Silencing by siRNA Duplexes on CREB Phos-
phorylation and Neuronal Differentiation in H19-7 Cells—Be-
sides using a dominant negative approach to implicate BTK, we
cedures” and used for substrates as indicated. 30 l of Sepharose 4B
beads was resuspended with Tris-buffered saline (1:1 ratio), and in vitro
kinase assay was performed by adding bacterially recombinant GST-
BTK with constitutive active kinase activity (GST-caBTK) for 60 min at
30 °C. The final eluates from the beads were resolved by SDS-PAGE
(8% gel) and visualized by autoradiography. The phosphorylation prod-
ucts corresponding to the molecular sizes of fusion GST-caBTK (G-BTK,
105 kDa) and GST-CREB (G-CREB, 67 kDa) proteins are indicated by
an arrow, respectively.
FIG. 4. BTK directly phosphorylates CREB in response to
bFGF in neuronal H19-7 cells. A and B, H19-7 cells were stimulated
with 10 ng/ml bFGF for the indicated times (A) or 30 min (B), and the
cell lysates were isolated. Total cell lysates were immunoprecipitated
with anti-BTK antibodies. The BTK levels in the immunocomplexes
were identified using polyclonal anti-BTK antibodies. In vitro kinase
assays were performed using bacterially expressed wild type GST-
CREB (wCREB) or mutant CREB (mCREB), in which the Ser-133
residue was replaced by Ala, as an exogenous substrate. Kinase reac-
tion products were resolved by 10% SDS-PAGE, and the levels of
phosphorylated CREB were visualized autoradiographically. IP, immu-
noprecipitation; No T, no treatment; Cont, control. C, the H19-7 cells
were untreated or stimulated for 30 min with 10 ng of bFGF/ml as
indicated, and total cell lysates were immunoprecipitated with anti-
BTK antibodies. The cell lysates containing 10–20 g of proteins were
resolved by SDS-PAGE on an 8% gel containing 50 g of bacterially
expressed wild type GST-CREB or mutant GST-CREB S133A
(mCREB)/ml as a substrate. The in-gel kinase renaturation assay was
performed as described under “Experimental Procedures.” A 77-kDa
CREB kinase activated by bFGF is indicated by an arrow (C, control; F,
bFGF). D, Sepharose 4B beads prebound to bacterially expressed fusion
proteins of wild type GST-CREB or the GST-CREB S133A mutant
(GST-mCREB) were prepared as described under “Experimental Pro-
FIG. 5. Effect of kinase-inactive BTK on FGF-induced CREB
phosphorylation in H19-7 cells. A, where indicated, H19-7 cells were
mock-transfected (No T and C) or transfected in a transient manner
with 5 g of cDNA construct encoding wild type or kinase-deficient
BTK, namely, K430E or Y551F/Y223A mutant. The cells were then
stimulated with 10 ng/ml bFGF for 30 min and the cell lysates isolated.
Total cell lysates were resolved by 10% SDS-PAGE and analyzed using
either polyclonal anti-CREB or anti-pCREB IgG. B, H19-7 cells were
mock-transfected or transfected with the plasmid encoding GFP fused
to double tyrosine-mutated BTK (Y223A/Y551F). The cells were then
either untreated or stimulated with 10 ng/ml bFGF for 30 min. Trans-
fected protein levels of the double tyrosine-mutated BTK were identi-
fied by Western blotting using anti-GFP antibodies. Total cell extracts
were immunoprecipitated (IP) with anti-BTK, and in vitro kinase assay
was performed using GST-CREB as a substrate. No T, no treatment; C,
control; WT, wild type; M1, K430E; 2MT, Y551F/Y223A.
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attempted to prove that BTK is the kinase responsible for
phosphorylating and activating CREB during neuronal differ-
entiation using double-stranded short RNA interference
(siRNA) technology. First, we examined whether endogenous
BTK protein can transiently be depleted using BTK siRNA
oligonucleotides. We synthesized siRNA duplexes specific for
BTK mRNA, the site being conserved on both the human and
the mouse gene (50). After the transfection of BTK siRNA
duplexes, Western blotting analysis demonstrated that BTK
silencing was remarkable up to 90% in H19-7 cells (Fig. 9A),
suggesting the specificity of siRNA silencing of endogenous
BTK expression. Second, to study the biological relevance of
endogenous BTK suppression by siRNA duplexes, we investi-
gated its effect on CREB phosphorylation and neurite out-
growth in H19-7 cells under neuronal differentiation. In bFGF-
stimulated cells, in vitro kinase assay showed that elevated
levels of phosphorylated CREB were significantly diminished
by the presence of siRNA for BTK (Fig. 9A). Furthermore, the
neurite outgrowth was also significantly decreased (by  65%)
when BTK expression was down-regulated by BTK siRNA du-
plexes (Fig. 9B). These results validated the specificity and
accuracy of our current findings, when siRNA down-regulation
was compared with the overexpression of kinase-deficient BTK
mutant proteins. Taken together, these results indicate that
BTK kinase activity is required for efficient CREB phosphoryla-
tion and therefore possibly influences neuronal differentiation.
The Activation of BTK in Response to bFGF Is Linked to the
Signaling Pathways Activated by Extracellular Signal-regu-
lated Protein Kinase, Phosphatidylinositol 3-Kinase, and Src
Kinase—To characterize the possible “cross-talk” between BTK
and the intracellular signaling pathways mediated by other
protein kinases, such as MAPK (or extracellular signal-regu-
lated protein kinase, ERK) or phosphatidylinositol 3-kinase
(PI-3K) in neuronal H19-7 cells, we examined the blockade
effect of each signaling pathway on the bFGF-induced activa-
tion of BTK and BTK-mediated CREB phosphorylation by us-
ing its synthetic chemical inhibitor or kinase-inactive mutant.
BTK activation has been reported to depend on PI-3K in im-
mune B cells (19, 29). In addition, sustained activation of ERK2
requires BTK during B cell antigen receptor-induced signaling
events in chicken DT40 B cell line (30). As shown in Fig. 10A,
when H19-7 cells were pretreated with the specific inhibitor of
MEK, PD98059, the activation of BTK and its kinase activity
was suppressed by bFGF to the level in control cells. Previously
it has been shown that bFGF exerts its stimulatory effect on
the activation of MEK-ERK (31). Furthermore, the same con-
centration of PD98059 was shown to inhibit the activation of
ERK by bFGF completely (32). In a similar way, pretreatment
of H19-7 cells with LY294002, the specific inhibitor of PI-3K,
completely inhibited the activation of BTK in response to bFGF
(Fig. 10A). As a control, it was shown that the activation of
PI-3K is induced upon bFGF stimulation and that the addition
of LY294002 blocks the activation of PI-3K by bFGF in H19-7
FIG. 6. Effect of BTK activation on CRE-mediated gene tran-
scription in H19-7 cells. Where indicated, the cells were mock-trans-
fected or 1 g of CRE-reporter plasmid, pCRE-TK-Luciferase (CRE-
Luc) was transiently transfected into H19-7 cells alone (Control) or with
1 g of plasmid encoding hemagglutinin-tagged kinase-dead BTK mu-
tant, namely K430E (M1), or double tyrosine-mutated Y223A/Y551F
(2MT). The cells were then either untreated or stimulated with 10 ng/ml
bFGF (FGF) for 4 h, and the luciferase activities of the reporter plasmid
were measured. The CRE-lacking TK promoter construct, pTK-Luc
(TK-Luc), was used as a negative control in every transfection experi-
ment. Data are plotted as percentages of maximum luciferase activity
and represent the means plus the range of sample results obtained from
independent experiments performed in triplicate. 1, Control; 2, FGF; 3,
TK-Luc  FGF; 4, CRE-Luc  FGF; 5, CRE-Luc  M1  FGF; 6,
CRE-Luc  2MT  FGF.
FIG. 7. Activation of BTK is important for neuronal differen-
tiation in hippocampal H19-7 cells. Where indicated, H19-7 cells
were mock-transfected (Vehicle) or transiently transfected with 5 g of
vectors expressing parental vector (P) or kinase-inactive BTK mutant,
namely, K430E (M1) and Y223A/Y551F (2MT). The cells were then
either untreated or stimulated with 10 ng/ml bFGF (FGF) under dif-
ferentiation conditions for 48 h, and changes in cell morphology were
observed under the optical microscope (A). Differentiated cell percent-
ages are expressed as ratios relative to the total cell numbers (B). The
results represent the means and the ranges in the data from two
independent experiments performed in triplicate.
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FIG. 8. Microinjection of kinase-deficient BTK or anti-BTK antibodies blocks the neurite outgrowth in H19-7 cells. A, where
indicated, H19-7 cells were transiently transfected with 2 g of pEGFP or pEGFP-BTK 2MT-Y223A/Y551F vector encoding GFP fused with
kinase-deficient BTK mutant, in which two Tyr residues in SH3 domain (Tyr-223) and kinase domain (Tyr-551) were mutated to Ala and Phe,
respectively. The cells were then either untreated or stimulated with 10 ng/ml bFGF under differentiation conditions for 48 h, and changes in cell
morphology of GFP-expressed were observed under the optical and fluorescence microscope (Olympus-DP50). B, H19-7 cells in Dulbecco’s modified
Eagle’s medium and 10% FBS were given microinjections of the affinity-purified cst-1 (4 mg/ml) and coinjection of rat gig 91 mg/ml) as a marker
for the injected cells. At 1 h after microinjection, the cells were switched to N2 medium, treated with bFGF, and shifted to 39 °C for 24–48 h. Cells
from the same field were visualized by immunofluorescence (left panel) and phase-contrast microscopy (right panel). Injected cells stained with
fluorescein isothiocyanate-conjugated anti-rat antibodies (Ab) are indicated by arrows. C, the percentages of differentiated cells in GFP-BTK-2MT
and BTK antibody microinjection were obtained from dividing the number of differentiated, GFP-expressing- and antibody-staining cells by the
total number of injected cells. A total of 101 GFP-BTK-2MT-injected cells and 109 anti-BTK IgG-microinjected cells were analyzed. As a control,
the total numbers of cells expressing GFP and control IgG counted were 124 and 111, respectively.
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cell (33). Taken together, the above indicates that the activa-
tion of both ERK and PI-3K is linked to and required for the
induction of BTK during neuronal differentiation in H19-7
cells.
The Src kinase family is involved in a broad range of cellular
responses ranging from cell division and cytoskeletal rear-
rangement in fibroblasts, to the differentiation of neuronal
cells (34–36). Many studies have demonstrated a role for
pp60Src tyrosine kinase (Src) in BTK-induced B cell mitogen-
esis via the phosphorylation of the Tyr-133 residue of BTK (13).
It was shown previously that Src kinase is also activated in
response to bFGF and that its activation is very important for
neuronal differentiation in H19-7 cell (32). To determine
whether Src kinase functions as a mediator of BTK signaling in
H19-7 cells, we assayed the effect of the inhibition of Src kinase
activity on BTK activation in response to bFGF. Fig. 10B shows
that the transfection of kinase-deficient Src mutant resulted in
the inhibition of FGF-induced BTK activity to the basal level in
H19-7 cells compared with mock-transfected control cells. Sim-
ilar results were obtained when the Src kinase activity was
inhibited using PP1, the selective Src kinase inhibitor (Fig.
10B). Furthermore, when v-Src, which is a constitutively active
tyrosine kinase, was transfected into H19-7 cells, the BTK
activity increased significantly in a constitutive manner and
was comparable with that induced by bFGF (Fig. 10B). These
findings indicate that FGF may use Src kinase for its down-
stream signaling leading to BTK activation.
DISCUSSION
Although the cellular functions of BTK family kinases have
been elucidated in immune cells, such as B cells, mast cells,
and platelets, their physiological roles are not known in neu-
ronal cells. In the present study, we show that endogenous BTK
FIG. 9. Effect of the suppression of endogenous BTK by siRNA
duplexes on bFGF-induced CREB phosphorylation and neuro-
nal differentiation. A, where indicated, H19-7 cells were mock-trans-
fected (No T or Con) or transfected with siRNA duplexes specific for
BTK mRNA (si). The cells were then either untreated (No T) or stim-
ulated with 10 ng/ml bFGF for 30 min. The endogenous BTK expression
in cell lysates and its suppression by siRNA duplexes were detected by
Western blotting using anti-BTK antibodies. The kinase activity of BTK
in the immunocomplexes obtained with anti-BTK antibodies was ana-
lyzed by in vitro kinase assay using GST-CREB as a substrate. B, the
changes in cell morphology under differentiation conditions for 48 h
were observed under the optical microscope, as indicated.
FIG. 10. Effect of ERK, PI-3K, or Src kinase on FGF-induced
BTK activation in H19-7 cells. A, H19-7 cells were untreated or
preincubated with either 30 M MEK inhibitor PD98059 (PD) or 10 M
PI-3K inhibitor LY294002 (LY) for 30 min prior to stimulation. The cells
were then stimulated with 10 ng/ml bFGF for 30 min and immunopre-
cipitated with anti-BTK antibodies. The immune complexes were re-
solved on 8% SDS-PAGE, blotted onto a nitrocellulose filter, and de-
tected with either anti-phosphotyrosine antibodies or anti-BTK IgG. An
in vitro CREB kinase assay was performed using bacterially expressed
wild type recombinant CREB proteins fused with GST as an exogenous
substrate. B, where indicated, the H19-7 cells were mock-transfected
(No T, F, and C) or transiently transfected with 5 g of plasmids
encoding viral Src kinase (vS) or kinase-inactive Src kinase (mS). The
cells were then either untreated or stimulated with bFGF (or F) for 30
min. The BTK was immunoprecipitated from the cell lysates and blot-
ted with monoclonal anti-phosphotyrosine antibodies. Where specified,
H19-7 cells were untreated or preincubated with 2.5 M PP1 for 30 min
before stimulating with 10 ng/ml bFGF for 30 min. Total cell lysates
were immunoprecipitated with anti-BTK antibodies and then detected
with anti-BTK or anti-phospho-Tyr (pTyr) IgG. In vitro kinase assay
was performed by using bacterially recombinant GST-CREB as a sub-
strate of BTK. C, control; IP, immunoprecipitation; No T, no treatment.
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is remarkably expressed in various mammalian neuronal cells.
In addition, BTK is activated by neurogenic bFGF, but not by
mitogenic EGF, and active BTK stimulates CREB phosphoryl-
ation and subsequent CRE-mediated gene transcription in im-
mortalized hippocampal H19-7 cells. Knowing that CREB
plays a crucial role in neuronal differentiation (17) and the
formation of learning and memory in various organisms (9), our
results strongly suggest that the activation of BTK plays an
important role during neuronal differentiation in embryonic
central nervous system progenitor cells. Such a role is sup-
ported further by the finding that the expression of kinase-
inactive BTK in a transient manner attenuates the formation
of differentiated cells.
In the present we also demonstrate that active BTK directly
phosphorylates CREB on Ser-133 by using in vitro kinase and
in vitro in-gel kinase assay. These data indicated that BTK is
classified as a dual specific protein kinase rather than protein
tyrosine kinase. Dual specificity protein kinases are usually
divided into three groups: kinases that show true dual speci-
ficity by phosphorylating Tyr and Ser/Thr residues of exoge-
nous substrates; kinases that exhibit dual specificity only
through autophosphorylation; and kinases that possess the
structural motif characteristic of dual specific kinases (1–3, 37,
38), and our data suggested that BTK belongs to the first
group. Further identification and characterization of its unique
substrates should resolve other physiological role(s) and sig-
naling network mediated by this kinase in neuronal cells.
BTK can translocate to the nucleus and utilizes functional
chromosomal region maintenance-dependent nuclear export
signals to shuttle between the nucleus and the cytoplasm (18).
This finding has implications regarding potential targets inside
the nucleus, which may be critical for gene regulation during
the development and differentiation of neuronal cells as well as
B cells. In accordance with this speculation, BTK is known to
phosphorylate many transcription factors, such as STAT5A,
BAP-135, Bright, and nuclear factor-B (27, 35–41). In addi-
tion, the present work shows that CREB is a phosphorylation
target of BTK in neuronal cells.
BTK family kinases contain a PH domain, which is found in
a wide range of signaling molecules including protein kinases,
phospholipases, GTPases, adaptor proteins, and cytoskeletal
proteins (42). The mutations in the PH domain of BTK have
been shown to associate with X-linked agammaglobulinemia,
suggesting an important role for the PH domain in the regula-
tion of BTK kinase activity (43, 44). Although the exact func-
tion of the PH domain has yet to be elucidated, accumulating
evidence suggests that PH domains are able to bind to phos-
pholipids and many proteins including heterotrimeric G pro-
teins, protein kinase C isoforms, STAT3, F-actin, Fas, and FAK
(16). The kinase domain of BTK appears to be critical for CREB
phosphorylation and subsequent CRE-mediated gene tran-
scription. Given the multimodular structure of the BTK family
kinases and the multitude of signaling molecules that can
interact with them, it is to be expected that these kinases
impact multiple signaling pathways and generate pleiotropic
effects (16). The BTK family kinases have the potential to
activate all of the major signaling pathways.
The current findings, namely, that the activation of BTK is
linked to the signaling pathways mediated by ERK, PI-3K, and
Src kinase, strongly suggest that BTK appears not to be a
previously identified novel CREB kinase, whose activation is
not linked to either ERK or PI-3K (23). Several studies have
found that BTK-activated signaling cascades are coupled with
MAPK and PI-3K. For example, the activation of BTK has been
correlated with the association of BTK and the cellular mem-
brane (16). Moreover, PI-3K activates BTK together with Src
family kinase (45). In addition, B cell antigen receptor-medi-
ated Akt stimulation is regulated by BTK, which regulates Akt
both proximal and distal to PI-3K activation, and BTK func-
tions downstream of PI-3K (46).
In terms of the regulation of BTK by MAPKs, multiple sig-
naling pathways, including the BTK, protein kinase C, and
SEK1 and MKK7 pathway, are suggested to be involved in the
activation of JNK in mast cells (47). In the chicken DT40 B cell
line c-Jun N-terminal kinase-1 (JNK-1) is activated via a BTK-
dependent pathway in response to B cell antigen receptor cross-
linking (30). In some cases, BTK appears to act upstream and
regulate the activation of MAPKs, such as ERK or JNKs in
immune B cells. For example, BTK directly regulates c-Jun
NH2-terminal kinase activity upon FcRI cross-linking, growth
factor stimulation, or growth factor deprivation (48). On the
contrary, the activation of BTK appears to be regulated by ERK
in neuronal H19-7 cells, suggesting that BTK is present down-
stream of ERK. This discrepancy may be possible by the differ-
ences in specific cellular environments.
We showed previously that the expression of dominant neg-
ative Src kinase or a microinjection of an anti-Src antibody
blocks the differentiation of H19-7 cells by bFGF, indicating
that bFGF signals through a Src kinase-mediated pathway
(32). Although constitutively activated v-Src was insufficient to
cause the differentiation of H19-7 cells, the coexpression of
v-Src with constitutively activated MEK induced neurite out-
growth. These results suggest that Src kinase activation is
necessary for differentiation by bFGF and that the differenti-
ation of H19-7 neuronal cells by bFGF requires signaling path-
ways activated by Ras and Src (32). In addition, our work
indicates that the differentiation signals of Src kinase are
transmitted through its downstream target BTK and the sub-
sequent activation of CREB in response to bFGF in H19-7 cells.
The overall consequences of the various signals transmitted
by the BTK family kinases are varied and include growth,
differentiation, and apoptosis (49). The involvement of BTK in
growth, differentiation, and development has long been recog-
nized in X-linked immunodeficiency and X-linked agamma-
globulinemia cells, as BTK deficiency leads to the failure of B
cells to proliferate upon antigen stimulation and subsequent
maturation. The ability of BTK to complement a weakly onco-
genic Src in the transformation of fibroblasts and the observa-
tion that Etk/Bmx is the key effector of Src in the transforma-
tion of hepatocytes and fibroblasts suggest their participation
in anchorage-independent growth (39, 45). On the basis of the
present finding that BTK activates CREB during neuronal
differentiation in central nervous system hippocampal cells,
further investigation of the upstream signaling pathways and
of the possible cross-talk between the many intracellular sig-
naling pathways may give deeper insight into the mechanism
of neuronal differentiation mediated by BTK activation.
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